Autoimmune diseases are a serious threat to human beings due to their complexity and systemic effects. Traditional therapies primarily involve immunosuppressive agents, which, while effective at reducing inflammation and autoimmunity, often come with adverse side effects, including increased susceptibility to infections and potential long-term organ damage. These challenges have prompted the exploration of innovative therapeutic agents and advanced drug delivery systems, aiming to enhance therapeutic efficacy while mitigating systemic toxicity. This chapter highlights the latest strides in autoimmune therapy, focusing on innovative compounds and novel delivery systems that promise to enhance patient outcomes. Firstly, we discuss the development of novel small molecules and biologics, which are directed at specific immune pathways linked to various autoimmune diseases. Such advancements are leading to more targeted treatments, while also minimizing side effects. Secondly, we explore the critical role that advanced drug delivery systems play in enhancing both the effectiveness and safety of autoimmune treatments. Nanotechnology-based platforms, including nanoparticles and liposomes, aid in the administration of medications or drugs to specific organs or cells, or tissues that are involved in autoimmune pathology. Additionally, controlled-release formulations offer the advantage of prolonged drug exposure, which not only reduces the frequency of dosing but also helps to maintain stable therapeutic levels in patients, minimizing systemic toxicity. Furthermore, we emphasize the significance of personalized medicine methods for the treatment of autoimmune diseases. Given the heterogeneity in disease manifestations and individual responses to treatment, personalized approaches are crucial. Integrating genomic and immunological profiling may aid healthcare providers in identifying optimal therapeutic strategies, tailored to the individual patient’s characteristics. Integrating novel compounds with advanced drug delivery systems presents a promising pathway for the creation of next-generation therapies for autoimmune diseases. However, further research and clinical studies are warranted to validate the safety and efficacy of these approaches and ultimately improve treatment outcomes for patients suffering from autoimmune diseases.